¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"body surface potential mapping"¿¡ ´ëÇÑ ´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximum permissible body burden
    ÃÖ´ëü³»Çã¿ëºÎ´ã(õÌÓÞô÷Ò®úÉé»Ý¶Ó½)
  • nu body
    nuü(ô÷)
  • nuclear body
    ÇÙü(ú·ô÷)
  • residual body
    ÀÜ¿© ¼Òü(íÑæ®á³ô÷)
  • whole body counter
    Àü½Å °èÃø±â (ͪö´Ðï)
  • X body
    X ü(ô÷)
  • contact surface
    Á¢Ã˸é(ïÈõºØü)
  • hepatitis B surface antigen
    BÇü(úþ) °£¿°(ÊÜæú) Ç¥¸é Ç׿ø(øúØüù÷ê«)
  • mixed surface film
    È¥ÇÕÇ¥¸é(ûèùêøúØü)Çʸ§
  • molecular surface
    ºÐÀÚÇ¥¸é(ÝÂí­øúØü)
  • reentrant surface
    ¿ä°¢ Ç¥¸é(èêÊÇøúØü)
  • surface-active agent
    Ç¥¸éȰ¼ºÁ¦ (øúØüüÀàõð¥)
  • surface activity
    Ç¥¸éȰ¼º (øúØüüÀàõ)
  • surface antigen
    Ç¥¸éÇ׿ø (øúØüù÷ê«)
  • surface balance
    Ç¥¸é(øúØü) Àú¿ï
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á